Accelerator Nordic AB
09 december 2011 | Accelerator Nordic AB
SPAGO Imaging develops a novel and proprietary tumor selective contrast agent for MRI, SPAGO Pix, which has the potential to significantly improve visualization of most soft tissue tumors.
Storlek: 101632 B
Ladda ner högupplöst bild ›